Get the Full Story, Without the Noise.
Get Started
SubscribeLogin
Israel-Hamas Conflict
Mother's Day
Vladimir Putin
Real Madrid
Manchester United
Soccer
Pope Francis
Premier League
Social Media
Champions League
Rugby
Baseball
Artificial Intelligence
Published • loading... • Updated

Paxlovid Weaker Against Current COVID-19 Variants

Summary by Medscape
A real-world study found that Pfizer's COVID-19 antiviral Paxlovid is now less effective at preventing hospitalization or death in high-risk patients as compared with earlier studies.

1 Articles

All
Left
Center
Right
MedscapeMedscape

Paxlovid Weaker Against Current COVID-19 Variants

A real-world study found that Pfizer's COVID-19 antiviral Paxlovid is now less effective at preventing hospitalization or death in high-risk patients as compared with earlier studies.

·United States
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Medscape broke the news in United States on Friday, September 22, 2023.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Coronavirus

Coronavirus

Pfizer

Pfizer

Medical

Medical

News
For You
SearchBlindspotLocal